ARTICLE | Clinical News
SOU-001: Phase II start
June 27, 2005 7:00 AM UTC
Sosei will begin in the second half a placebo-controlled, U.K. Phase II trial in 24 female volunteers with SUI. Patients will receive single oral doses of SOU-001. The compound originally was develope...